Orthopediatrics (KIDS) Liabilities and Shareholders Equity (2016 - 2026)

Orthopediatrics (KIDS) has reported Liabilities and Shareholders Equity for 11 consecutive years, with $502.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 6.79% year-over-year to $502.2 million; the TTM figure through Mar 2026 stood at $2.0 billion (up 7.75% YoY), while the FY2025 annual figure was $508.6 million, up 7.49% from the prior year.
• Liabilities and Shareholders Equity eased to $502.2 million in Q1 2026 per KIDS's latest filing, from $508.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $508.6 million in Q4 2025 and bottomed at $301.0 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $443.0 million across 5 years, with a median of $437.2 million in 2024.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 41.65% in 2022 and fell as far as 3.94% in 2022.
• Orthopediatrics' Liabilities and Shareholders Equity stood at $427.7 million in 2022, then grew by 2.58% to $438.7 million in 2023, then advanced by 7.86% to $473.2 million in 2024, then gained by 7.49% to $508.6 million in 2025, then dropped by 1.27% to $502.2 million in 2026.
• Business Quant data shows KIDS's Liabilities and Shareholders Equity at $502.2 million in Q1 2026, $508.6 million in Q4 2025, and $493.5 million in Q3 2025.